NZ didnt make any money in the first half, but if some kind of recovery there was priced into FY25 that might be a negative. Not sure of the consensus, but obviously redeploying capital to a higher return is better in the long run for the company, if it has been judged a recovery there is not worth sticking around for.
re: regulatory issues, those are going to cost, be sure of that. Already millions in legal fees.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)